BN Business News
添加企业 →
本文翻译正在准备中。在此之前,我们暂时显示英文原文。

监管与法律 · 2010/2/11 分钟阅读

Registration Requirements for Importers and Manufacturers of Prescription Drug Products Containing Ephedrine, Pseudoephedrine, or Phenylpropanolamine

本地自动翻译 · 来源原始语言

摘要

The Drug Enforcement Administration (DEA) is amending its registration regulations to ensure that a registration is obtained for every location where ephedrine, pseudoephedrine, or phenylpropanolamine, or drug products containing one of these chemicals, are imported or manufactured. These amendments will make it possible to establish the system of quotas and assessment of annual needs for the importation and manufacture of these chemicals that Congress mandated in the Combat Methamphetamine Epidemic Act of 2005.

来源原始语言: Federal Register — Justice Department打开原始公告 →

探索专题

商业洞察 →